Related Experiment Videos
Bleomycin-induced pulmonary fibrosis in the rat: inhibition by indomethacin
Abstract:
A model for pulmonary fibrosis in the rat has been developed using intratracheal administration of bleomycin. The histopathologic features of the reaction are similar to those reported in the hamster model. Increases in vascular permeability are seen in the lung within 24 hours and persist over a 2-month period. Extractable collagen, as measured by hydroxyproline, increases during this time by a factor greater than 1.5 times the reference control values of normal lung. During this same period, a prominent eosinophilia develops. The continued treatment of bleomycin-injected rats with indomethacin markedly diminishes the amount of extractable lung collagen at 60 days and the histopathologic evidence of pulmonary fibrosis. The eosinophilia over the first 3 weeks is also markedly suppressed. Less dramatic effects were seen with the permeability changes. These findings indicate that the rat is a reliable and useful model for the study of blemoycin-induced pulmonary fibrosis and that treatment with indomethacin ameliorates the lung changes.
Insights
This study establishes a rat model for pulmonary fibrosis using bleomycin, demonstrating indomethacin
Area of Science:
- Pulmonary Medicine
- Toxicology
- Pharmacology
Background:
- Pulmonary fibrosis is a debilitating lung disease with limited treatment options.
- Animal models are crucial for understanding disease mechanisms and testing therapeutics.
- The bleomycin-induced lung injury model is widely used but requires validation in different species.
Purpose of the Study:
- To develop and characterize a rat model of pulmonary fibrosis induced by bleomycin.
- To investigate the efficacy of indomethacin in ameliorating bleomycin-induced lung injury and fibrosis in rats.
Main Methods:
- Intratracheal administration of bleomycin to induce pulmonary fibrosis in rats.
- Histopathological assessment of lung tissue for fibrosis.
- Measurement of lung collagen content (hydroxyproline) and vascular permeability.
- Evaluation of eosinophil infiltration in lung tissue.
- Treatment of bleomycin-injected rats with indomethacin.
Main Results:
- Bleomycin induced significant increases in lung collagen and vascular permeability, with prominent eosinophilia.
- Histopathological findings in rats mimicked those in established hamster models.
- Indomethacin treatment markedly reduced lung collagen and histopathological signs of fibrosis.
- Indomethacin also significantly suppressed eosinophilia, with less impact on permeability changes.
Conclusions:
- The rat is a reliable and valuable model for studying bleomycin-induced pulmonary fibrosis.
- Indomethacin demonstrates therapeutic potential by ameliorating key pathological features of lung fibrosis in this model.
- This model facilitates further research into the pathogenesis and treatment of pulmonary fibrosis.